BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8538314)

  • 1. Treatment of Crohn's disease fistulas with coagulation factor XIII.
    Oshitani N; Nakamura S; Matsumoto T; Kobayashi K; Kitano A
    Lancet; 1996 Jan; 347(8994):119-20. PubMed ID: 8538314
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined use of factor XIII and endoscopic balloon dilatation in a patient with Crohn's disease, duodenal stenosis, and associated internal fistulas: the efficacy of coagulation factor XIII for the internal fistulas.
    Kamata N; Oshitani N; Suekane T; Sogawa M; Yamagami H; Watanabe K; Fujiwara Y; Arakawa T
    Am J Gastroenterol; 2008 Jun; 103(6):1573-4. PubMed ID: 18510623
    [No Abstract]   [Full Text] [Related]  

  • 3. Deficiency of blood coagulation factor XIII in Crohn's disease.
    Oshitani N; Kitano A; Hara J; Suzuki N; Aoki T; Yasuda K; Watanabe Y; Obayashi M; Obata A; Nakamura S
    Am J Gastroenterol; 1995 Jul; 90(7):1116-8. PubMed ID: 7611208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of elemental enteral alimentation in Crohn's fistula.
    Takazoe M; Kondoh K; Hamada T; Shimada K; Iwadare J; Matsueda K
    J Gastroenterol; 1995 Nov; 30 Suppl 8():88-90. PubMed ID: 8563900
    [No Abstract]   [Full Text] [Related]  

  • 5. [Factor XIII deficiency as the cause of postoperative hemorrhage].
    Quiel V
    Zentralbl Gynakol; 1993; 115(12):562-4. PubMed ID: 8147170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entero-cutaneous fistulas and Crohn's disease.
    Keighley Mr; Heyen F; Winslet MC
    Acta Gastroenterol Belg; 1987; 50(5):580-600. PubMed ID: 3332527
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic strategies of fistulous Crohn's disease: medical or surgical treatment?].
    Bouhnik Y; Panis Y
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S98-103. PubMed ID: 12704303
    [No Abstract]   [Full Text] [Related]  

  • 8. Ileouterine fistulae: possible predisposing factors to this rare complication of Crohn's disease.
    Steinlauf AF; Marion JF; Sacchar D; Sandler AL; Greenstein AJ; Harris MT
    Inflamm Bowel Dis; 2011 Mar; 17(3):872-3. PubMed ID: 20602468
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of medical treatment on patients with fistulizing Crohn's disease: a retrospective study.
    Uza N; Nakase H; Ueno S; Inoue S; Mikami S; Tamaki H; Matsuura M; Chiba T
    Intern Med; 2008; 47(4):193-9. PubMed ID: 18277016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of fistulas in Crohn's disease with infliximab.
    Löfberg R
    Gut; 1999 Nov; 45(5):642-3. PubMed ID: 10517896
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian involvement in Crohn´s disease: A rare complication.
    Saborit R; Roig A; García Del Caño J; Viciano V; Aguiló J
    Rev Esp Enferm Dig; 2016 Feb; 108(2):100-3. PubMed ID: 26838494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of administration of coagulation factor XIII with definitive surgery for multiple intractable enterocutaneous fistulae in a patient with decreased factor XIII activity.
    Saigusa S; Yamamura T; Tanaka K; Ohi M; Kawamoto A; Kobayashi M; Inoue Y; Kusunoki M
    BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22698903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of fibrostenotic and fistulizing Crohn's disease.
    Schoepfer AM; Safroneeva E; Vavricka SR; Peyrin-Biroulet L; Mottet C
    Digestion; 2012; 86 Suppl 1():23-7. PubMed ID: 23051723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intestinal fistula in Crohn disease].
    Morales V; Enríquez JM; Camuñas J; Fernández J; Carda P; Devesa M; Moreira V
    Rev Esp Enferm Apar Dig; 1989 Aug; 76(2):115-9. PubMed ID: 2813899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stem Cells to Treat Crohn's Disease with Fistula.
    Zhang XM; Zhang YJ; Wang W; Wei YQ; Deng HX
    Hum Gene Ther; 2017 Jul; 28(7):534-540. PubMed ID: 28132518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It's What's Up Front That Counts-Part One: Endoscopic Diagnosis and Therapy of Esophageal Crohn's Disease.
    Alli-Akintade L; Hewitt J; Namiq A; Singh M; Nguyen Y; Keihanian S; Chang JT; Karsan S; Tesfay S; Velayos FS
    Dig Dis Sci; 2019 Nov; 64(11):3100-3103. PubMed ID: 31529414
    [No Abstract]   [Full Text] [Related]  

  • 17. [Substitution of F XIII concentrate in ulcerative colitis].
    Lorenz R; Clemens R; Karl M; Classen M
    Z Gastroenterol; 1989 Feb; 27(2):87-90. PubMed ID: 2658393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.
    Sosa R; Gailani D; Neff AT
    Haemophilia; 2014 Nov; 20(6):e429-32. PubMed ID: 25333572
    [No Abstract]   [Full Text] [Related]  

  • 19. [Substitution with blood coagulation factor XIII concentrates in patients with acute leukemia].
    Rasche H
    Beitr Infusionther Klin Ernahr; 1986; 15():179-86. PubMed ID: 3530242
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of abscess and enterocutaneous fistula in a patient with Crohn's disease: case report.
    Ring KS
    Mt Sinai J Med; 1987 Jun; 54(5):450-5. PubMed ID: 2958703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.